Australian clinical trials company Evrima has raised $3 million to boost its aim to double headcount and grow the capabilities of its tech platform.
Several companies, including IQVIA, the firm managing AstraZeneca's COVID vaccine trial, and Bristol Myers Squibb, which is leading a group of companies in developing a quick coronavirus test, have been affected by a ransomware attack on Windows systems at Philadelphia firm eResearchTechnology.
ASX-listed Opyl has a two-pronged approach to applying AI to healthcare.
Australian clinical trials startup HealthMatch has released a global COVID-19 clinical trials tracker to map developments on research breakthroughs around the world.
Australian-listed software as a service company ShareRoot is collaborating with St Vincent’s Hospital in Melbourne to apply its MediaConsent platform as a way to improve the dynamics of clinical trial recruitment.
Most cybersecurity is making up for weak platforms. We need to address the fundamentals, design platforms that prevent out-of-bounds access[…]
For most developers the security/performance trade off is still the hardest one to tackle, even as the cost of processing[…]
RISC has been overhyped. While it is an interesting low-level processor architecture, what the world needs is high-level system architectures,[…]
There are two flaws that are widespread in the industry here. The first is that any platform or language should[…]
Ajai Chowdhry, one of the founders and CEO of HCL is married to a cousin of a cousin of mine.[…]